Dennis Podlesak

Dennis G.
Podlesak was the founder of Cerexa, Inc., founded in 2005, where the title held was Chief Executive Officer & Director from 2005 to 2007.
Mr. Podlesak was the founder of Calixa Therapeutics, Inc., founded in 2007, where the title held was Chief Executive Officer & Director from 2007 to 2009.
Mr. Podlesak is also the founder of Transposon Therapeutics, Inc...
Mr. Podlesak is currently Chairman at Syndax Pharmaceuticals, Inc. since 2008.
Mr. Podlesak is currently Chairman at Adynxx, Inc. Mr. Podlesak is currently Director at Domain Russia Investments Ltd. Mr. Podlesak is currently Venture Partner at Domain Associates LLC since 2020.
Mr. Podlesak is currently Partner at Domain LLC.
Former positions include President, Chief Executive Officer & Director at Peninsula Pharmaceuticals, Inc. from 2005 to 2006.
Executive Chairman at Corthera, Inc. Chairman at Tobira Therapeutics, Inc. from 2015 to 2016.
Independent Director at Avanir Pharmaceuticals, Inc. from 2005 to 2015.
Director at DOV Pharmaceutical, Inc. Director at Regado Biosciences, Inc. from 2007 to 2009.
Director at Adastra Pharmaceuticals, Inc. Director at Adynxx, Inc. (Old) Director at Kalidex Pharmaceuticals, Inc. Director at National Society to Prevent Blindness Director at RightCare Solutions, Inc. Director at Exalys Therapeutics, Inc. Vice President & Head-Eye Care Division at Allergan, Inc. from 1998 to 2002.
Senior VP & Head-North American Business Unit at Novartis AG.
Member-Executive Committee at Novartis Pharmaceuticals Corp.
Principal at GlaxoSmithKline LLC.
Education includes undergraduate and MBA degrees from Pepperdine University, an undergraduate degree from Western Illinois University conferred in 1979, and a graduate degree from The Wharton School of the University of Pennsylvania.